BCIQ Profiles

Company Profile Report
0701 ECP OnCusp
BioCentury & Getty Images

Emerging Company Profile

OnCusp: Bing Yuan’s newco to provide bridge from innovation to MNC

Emerging Company Profile: OnCusp launches to license, develop early stage cancer therapies before out-licensing assets to MNCs

OnCusp launches to license and develop early stage cancer therapies sourced in the U.S. and China, aiming to reach POC before out-licensing to MNCs.

Jul 2, 2021 | 1:34 AM GMT

Former CStone and Merck & Co. dealmaker Bing Yuan and his OnCusp co-founders are using their early stage drug hunting skills to

Read the full 863 word article

How to gain access

Continue reading with a
two-week free trial.